Facial Injectables Market 2017-2021 report estimates the global facial injectables market to reach nearly US$ 7.8 Billion in 2020, at a CAGR of 9.3% from 2017 to 2021 – iHealthcareAnalyst, Inc.
Visit the Facial Injectables Market 2017-2021 report https://www.ihealthcareanalyst.com/report/facial-injectables-market/
The global facial injectables market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
Facial rejuvenation is a cosmetic treatment performed to restore a youthful appearance to the human face and it can be achieved through either surgical and/or non-surgical options. Procedures can vary in invasiveness and depth of treatment. Surgical procedures can restore facial symmetry through targeted procedures and facial restructuring and skin alterations. Non-surgical procedures can target specific depths of facial structures and treat localized facial concerns such as wrinkles, skin laxity, hyperpigmentation and scars. Surgical (invasive) facial rejuvenation procedures can include a brow lift (forehead lift), eye lift (blepharoplasty), facelift (rhytidectomy), chin lift and neck lift. Non-surgical (non-invasive) facial rejuvenation treatments can include chemical peels, neuromodulator (such as botox), dermal fillers, laser resurfacing, photorejuvenation, radiofrequency and Ultrasound.
The global facial injectables market segmentation is based on product types (Botulinum Toxin, Hyaluronic Acid, Collagen, Particles and Polymers Fillers (PPF), Polymethylmethacrylate beads (PMMA microspheres), Poly-L-lactic acid, Calcium hydroxyapatite). The global facial injectables market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global facial injectables market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
- Product Type
- Botulinum Toxin
- Hyaluronic Acid
- Particles and Polymers Fillers (PPF)
- Calcium hydroxyapatite
- Poly-L-lactic acid
- Polymethylmethacrylate beads (PMMA microspheres)
- Geography (Region, Country)
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Rest of LA)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Rest of the World
- Company Profiles
- Bloomage BioTechnology Corporation Limited
- Galderma S.A.
- Ipsen Group
- Merz Pharma GmbH & Co. KGaA
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.